Beranda › Penyakit Sel Sabit
Uji klinis Penyakit Sel Sabit yang merekrut di AS
107 studi untuk Penyakit Sel Sabit merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Atlanta, GA22 studi
- Washington, DC20 studi
- Chicago, IL18 studi
- Memphis, TN18 studi
- Philadelphia, PA15 studi
- Birmingham, AL14 studi
- New York City, NY13 studi
- St. Louis, MO12 studi
- Durham, NC10 studi
- Houston, TX10 studi
- Boston, MA10 studi
- Cincinnati, OH10 studi
- Columbus, OH9 studi
- Pittsburgh, PA9 studi
- Greenville, NC9 studi
- The Bronx, NY8 studi
- Baltimore, MD7 studi
- Los Angeles, CA7 studi
- Charlotte, NC7 studi
- Cleveland, OH7 studi
- Oakland, CA7 studi
- Nashville, TN6 studi
- Richmond, VA6 studi
- Hartford, CT5 studi
- Phoenix, AZ5 studi
- Detroit, MI5 studi
- Indianapolis, IN5 studi
- Augusta, GA5 studi
- Jackson, MS5 studi
- New Orleans, LA4 studi
- New Haven, CT4 studi
- Milwaukee, WI4 studi
- Greenville, SC4 studi
- Arlington, VA4 studi
- Rochester, NY3 studi
- Winston-Salem, NC3 studi
- Newark, NJ3 studi
- Little Rock, AR3 studi
- Queens, NY3 studi
- Greenburgh, NY3 studi
Berdasarkan negara bagian
- Alabama16 studi
- Arizona5 studi
- Arkansas3 studi
- California18 studi
- Connecticut7 studi
- Delaware6 studi
- Distrik Columbia10 studi
- Florida9 studi
- Georgia25 studi
- Illinois19 studi
- Indiana5 studi
- Louisiana5 studi
- Maryland17 studi
- Massachusetts10 studi
- Michigan9 studi
- Minnesota5 studi
- Mississippi5 studi
- Missouri13 studi
- New Jersey8 studi
- New York21 studi
- North Carolina18 studi
- Ohio22 studi
- Pennsylvania20 studi
- South Carolina6 studi
- Tennessee22 studi
- Texas11 studi
- Virginia9 studi
- Wisconsin4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT04055818Blood Sampling for Research Related to Sickle Cell Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT00542230A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Menerima pesertaFase 3
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06439082Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Menerima pesertaFase awal 1
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06313398A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07656415Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT03937817A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07187973Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05170412A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Menerima pesertaFase 3
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06609226Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT05904093A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06612268Tocilizumab for Acute Chest Syndrome
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05640271Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT02824471Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
Menerima pesertaStudi observasional
Usia 2 hingga 99 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06944067Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
Menerima peserta
Usia 8 hingga 18 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07562451Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Menerima pesertaFase 1
Usia 8 hingga 17 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07226219Early Screening and Treatment of Heart Complication in Sickle Cell Disease
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07023666A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 12 hingga 55 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06546670SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06442761Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Menerima pesertaFase 1/2
Usia 4 hingga 65 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07599176Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Menerima pesertaFase 2
Usia 5 hingga 20 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07369024Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Menerima pesertaFase 1
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07566494Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography
Menerima pesertaSukarelawan sehat diterima
Usia 6 hingga 70 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07776444A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Menerima pesertaFase 2/3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT05431088A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06481306Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.